MarketWatch

As Tesla has doubled down on artificial intelligence, investors are left trying to make sense of the company’s progress. According to analysts at Oppenheimer, tracking how Tesla spends its cash may provide some insight.

Midjourney is making a foray into healthcare with its latest body-scanner product, aiming to make medical imaging more accessible.

Hyperventilating experts were wrong about the Iran war. The end of the conflict is a massive buy signal for stocks.

Billions of dollars have flowed into SpaceX ETFs as retail investors look past conventional valuations.

Intel “is steadily expanding its domestic capacity and converting political and strategic tailwinds into concrete foundry wins,” an analyst says.

The consulting company’s outlook came up short of expectations, and at least one analyst wonders if newly announced deals will bring complex integration challenges.

Demand for memory chips will continue to outpace supply in the near term despite efforts to add manufacturing capacity, an analyst says.